Anixa Biosciences (ANIX) Net Cash Flow (2010 - 2026)
Anixa Biosciences (ANIX) recorded Net Cash Flow of -$79,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$415,000 a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Net Cash Flow (2010 - 2026) Analysis & Trends
On a TTM basis, Anixa Biosciences' Net Cash Flow came in at $112,000 as of Jul 31, 2026, down 58.5% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at -$27,000.
- Across earlier fiscal years, Net Cash Flow came in at $356,000 in FY2024, -$11.45 million in FY2023, -$16.77 million in FY2022 and $22.71 million in FY2021 (+676.3%).
- The fiscal Q3 2026 figure is the highest quarterly Net Cash Flow since fiscal Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | -79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -79,000.00 |
| Oct 31, 2025 | -251,000.00 |
| Jul 31, 2025 | -415,000.00 |
| Apr 30, 2025 | 857,000.00 |
| Jan 31, 2025 | -218,000.00 |
| Oct 31, 2024 | 46,000.00 |
| Jul 31, 2024 | 230,000.00 |
| Apr 30, 2024 | -3,000.00 |
| Jan 31, 2024 | 83,000.00 |
| Oct 31, 2023 | -2.28 Mn |
| Jul 31, 2023 | -2.42 Mn |
| Apr 30, 2023 | -4.17 Mn |
| Jan 31, 2023 | -2.57 Mn |
| Oct 31, 2022 | -11.89 Mn |
| Jul 31, 2022 | -3.48 Mn |
| Apr 30, 2022 | -2.06 Mn |
| Jan 31, 2022 | 653,000.00 |
| Oct 31, 2021 | 1.91 Mn |
| Jul 31, 2021 | -481,000.00 |
| Apr 30, 2021 | 15.72 Mn |
API Access
Anixa Biosciences Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();